$13.79
0[0.00%]
At close: Apr 18
$13.79
0[0.00%]
PreMarket: 4:00PM EDT
Healthcare Realty Trust
(NYSE:HR)Healthcare Realty Trust Stock (NYSE:HR), Analyst Ratings, Price Targets, Predictions
Healthcare Realty Trust Inc has a consensus price target of $19.89, established from looking at the 29 latest analyst ratings. The last 3 analyst ratings were released from Wells Fargo, JP Morgan, and Wedbush on April 10, 2024, March 6, 2024, and February 20, 2024. With an average price target of $15.67 between Wells Fargo, JP Morgan, and Wedbush, there's an implied 13.61% upside for Healthcare Realty Trust Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Wells Fargo
JP Morgan
Wedbush
Stifel
Deutsche Bank
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Healthcare Realty Trust
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/10/2024 | HR | Buy Now | Healthcare Realty Trust | $13.79 | 8.77% | Wells Fargo | Connor Siversky | $18 → $15 | Maintains | Equal-Weight | Get Alert |
| 03/06/2024 | HR | Buy Now | Healthcare Realty Trust | $13.79 | 23.28% | JP Morgan | Michael Mueller | $19 → $17 | Maintains | Overweight | Get Alert |
| 02/20/2024 | HR | Buy Now | Healthcare Realty Trust | $13.79 | 8.77% | Wedbush | Richard Anderson | $19 → $15 | Downgrade | Outperform → Neutral | Get Alert |
| 02/20/2024 | HR | Buy Now | Healthcare Realty Trust | $13.79 | 8.77% | Stifel | Stephen Manaker | $19 → $15 | Downgrade | Buy → Hold | Get Alert |
| 01/30/2024 | HR | Buy Now | Healthcare Realty Trust | $13.79 | 30.53% | Deutsche Bank | Omotayo Okusanya | → $18 | Initiates | → Hold | Get Alert |
| 11/13/2023 | HR | Buy Now | Healthcare Realty Trust | $13.79 | 16.03% | Wells Fargo | Connor Siversky | $17 → $16 | Maintains | Equal-Weight | Get Alert |
| 11/06/2023 | HR | Buy Now | Healthcare Realty Trust | $13.79 | 23.28% | Wedbush | Richard Anderson | → $17 | Reiterates | Outperform → Outperform | Get Alert |
| 10/24/2023 | HR | Buy Now | Healthcare Realty Trust | $13.79 | 23.28% | BTIG | Michael Gorman | → $17 | Upgrade | Neutral → Buy | Get Alert |
| 10/12/2023 | HR | Buy Now | Healthcare Realty Trust | $13.79 | 37.78% | JP Morgan | Michael Mueller | → $19 | Upgrade | Neutral → Overweight | Get Alert |
| 10/10/2023 | HR | Buy Now | Healthcare Realty Trust | $13.79 | 23.28% | Scotiabank | Nicholas Yulico | $19 → $17 | Maintains | Sector Perform | Get Alert |
| 10/06/2023 | HR | Buy Now | Healthcare Realty Trust | $13.79 | 23.28% | BMO Capital | Juan Sanabria | $20 → $17 | Maintains | Market Perform | Get Alert |
| 10/03/2023 | HR | Buy Now | Healthcare Realty Trust | $13.79 | 23.28% | Wedbush | Richard Anderson | → $17 | Initiates | → Outperform | Get Alert |
| 08/22/2023 | HR | Buy Now | Healthcare Realty Trust | $13.79 | 23.28% | Citigroup | Michael Griffin | $19 → $17 | Maintains | Neutral | Get Alert |
| 08/11/2023 | HR | Buy Now | Healthcare Realty Trust | $13.79 | 74.04% | Barclays | Steve Valiquette | $25 → $24 | Maintains | Equal-Weight | Get Alert |
| 05/11/2023 | HR | Buy Now | Healthcare Realty Trust | $13.79 | 81.29% | Barclays | Steve Valiquette | $24 → $25 | Maintains | Overweight | Get Alert |
| 04/19/2023 | HR | Buy Now | Healthcare Realty Trust | $13.79 | — | Wells Fargo | Connor Siversky | — | Initiates | → Equal-Weight | Get Alert |
| 03/29/2023 | HR | Buy Now | Healthcare Realty Trust | $13.79 | 74.04% | Barclays | Steve Valiquette | $28 → $24 | Maintains | Overweight | Get Alert |
| 03/06/2023 | HR | Buy Now | Healthcare Realty Trust | $13.79 | 45.03% | Credit Suisse | Omotayo Okusanya | $23 → $20 | Downgrade | Outperform → Neutral | Get Alert |
| 12/14/2022 | HR | Buy Now | Healthcare Realty Trust | $13.79 | 45.03% | Citigroup | Michael Griffin | $22.5 → $20 | Downgrade | Buy → Neutral | Get Alert |
FAQ
What is the target price for Healthcare Realty Trust (HR)?
The latest price target for Healthcare Realty Trust (NYSE: HR) was reported by Wells Fargo on April 10, 2024. The analyst firm set a price target for $15.00 expecting HR to rise to within 12 months (a possible 8.77% upside). 15 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Healthcare Realty Trust (HR)?
The latest analyst rating for Healthcare Realty Trust (NYSE: HR) was provided by Wells Fargo, and Healthcare Realty Trust maintained their equal-weight rating.
When was the last upgrade for Healthcare Realty Trust (HR)?
The last upgrade for Healthcare Realty Trust Inc happened on October 24, 2023 when BTIG raised their price target to $17. BTIG previously had a neutral for Healthcare Realty Trust Inc.
When was the last downgrade for Healthcare Realty Trust (HR)?
The last downgrade for Healthcare Realty Trust Inc happened on February 20, 2024 when Wedbush changed their price target from $19 to $15 for Healthcare Realty Trust Inc.
When is the next analyst rating going to be posted or updated for Healthcare Realty Trust (HR)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Healthcare Realty Trust, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Healthcare Realty Trust was filed on April 10, 2024 so you should expect the next rating to be made available sometime around April 10, 2025.
Is the Analyst Rating Healthcare Realty Trust (HR) correct?
While ratings are subjective and will change, the latest Healthcare Realty Trust (HR) rating was a maintained with a price target of $18.00 to $15.00. The current price Healthcare Realty Trust (HR) is trading at is $13.79, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.